LAURSEN VAN SWIETEN
Laursen Van Swieten is an expansion-focused active investment firm. We fund and manage cross-border expansions of innovative B2B early and growth-stage companies. Helping companies achieve and maintain global leadership * active support for cross-border expansion, growth and turnaround * investment coupled with active management * extensive experience & access in Asia and Europe
LAURSEN VAN SWIETEN
Social Links:
Industry:
Biotechnology Health Care Industrial Industrial Automation Media And Entertainment Medical Device
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Euro Microsoft Exchange Online Amazon Office 365 Mail Person Schema COVID-19 Gravatar Profiles Amazon Route 53 Amazon S3 CDN
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-02 | PropTexx | Laursen van Swieten investment in Seed Round - PropTexx | N/A |
| 2021-07-02 | PropTexx | Laursen van Swieten investment in Private Equity Round - PropTexx | N/A |
| 2020-12-01 | Silenseed | Laursen van Swieten investment in Series A - Silenseed | N/A |
| 2019-06-01 | Soltaro | Laursen van Swieten investment in Private Equity Round - Soltaro | N/A |
More informations about "Laursen van Swieten"
Laursen van Swieten - Crunchbase Investor Profile & Investments
Laursen van Swieten invests in early to late-stage biopharma and biotechnology companies, focusing on health care and science sectors, with a geographical spread across Israel and …See details»
Laursen van Swieten – Expansion as a Venture
The key to Asia expansion is working with a trustworthy local partner. LvS funds and executes international expansions of innovative growth-stage companies.See details»
Laursen van Swieten - Investments, Portfolio & Company Exits
Dec 1, 2020 · Laursen van Swieten has made 2 investments. Their most recent investment was on Dec 1, 2020, when Silenseed raisedSee details»
Laursen Van Swieten investment portfolio | PitchBook
Jun 1, 2019 · Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Laursen Van Swieten. Use the PitchBook Platform to explore the full profile.See details»
Laursen van Swieten - Funding, Financials, Valuation & Investors
Laursen van Swieten is an active investor.See details»
Laursen van Swieten - LinkedIn
Laursen van Swieten is an expansion-focused active investor. | Laursen van Swieten is an expansion-focused active investor. We help tech companies achieve and maintain global …See details»
Laursen van Swieten - Investor Profile, Portfolio & Team - Tracxn
May 16, 2024 · Laursen van Swieten - Private fund focused on biotech and software sectors. Portfolio of 9 companies. Team has 2 members.See details»
Investor Connect: Gerard van Swieten of LvS Partners
Aug 10, 2021 · Laursen van Swieten (LvS) specializes in funding and executing the international expansion of innovative growth-stage companies. They are especially active and experienced in Asia/China expansion. They make active …See details»
Laursen van Swieten starts as China expansion manager of ORCA
Aug 5, 2021 · Laursen van Swieten starts as China expansion manager of ORCA. August 5, 2021 Share: More Posts. Why we focus on Energy Storage November 21, 2022 Europe faces the …See details»
Laursen van Swieten - EcoLabs
Laursen van Swieten China-focused expansion investment firm Ecolabs-COI is established to build and accelerate deep-tech energy inovation capabilities in Singapore to support the …See details»
Silenseed - Funding, Financials, Valuation & Investors - Crunchbase
Silenseed is a biopharmaceutical company that focuses on the development of cancer therapies.See details»
Silenseed - Crunchbase Company Profile & Funding
Silenseed is located in Jerusalem, Yerushalayim, Israel. Who invested in Silenseed? Silenseed is funded by Laursen van Swieten. How much funding has Silenseed raised to date? Silenseed …See details»
2020 Annual Update to Stakeholders - Laursen van Swieten
On March 28th, 2022, Shanghai started going into a city-wide lockdown to combat the new spread of the omicron variant of Covid-19. The lockdowns wereSee details»
Capturing China’s Biotech Opportunity: Why and How - Laursen …
Sep 19, 2020 · LvS works with Chinese industry experts to navigate the process and fast-track biotech innovations, as well as share technical insights with global investors through virtual …See details»
Investor Connect – 585 – Gerard van Swieten of LvS Partners
Aug 10, 2021 · In this episode, Hall welcomes Gerard van Swieten, Managing Partner at LvS Partners.Laursen van Swieten (LvS) specializes in funding and executing the international …See details»
Laursen van Swieten - Tech Stack, Apps, Patents & Trademarks
Nov 10, 2024 · Laursen van Swieten is an active investor. Start Free Trial . Chrome ExtensionSee details»
Building High Performance Chinese Teams - Laursen van Swieten
Aug 27, 2021 · Families of the bride and groom are increasingly putting funds together for the first marital home, but income and career perspective remain a major factor in employee decision …See details»
The development of tool use: Planning for end-state comfort
To study the development of planning, one needs a task with multiple steps in a hierarchical organization, a task with a motivating and obvious end point that can be reached by different …See details»
Strategy - Laursen van Swieten
For companies outside Asia ASIA WILL EITHER BECOME YOUR BIGGEST MARKET, OR BIGGEST COMPETITOR. The Asian Century 01 Economy Asia is the largest economic block …See details»
Energy and Manufacturing in China: Insights from ... - Laursen van …
Feb 19, 2021 · China is a strong growth market for energy and manufacturing sectors. During the collaboration between Ecolabs and LvS partners we found several key insights to achieving …See details»